Actively Recruiting
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
Led by Ohio State University Comprehensive Cancer Center · Updated on 2026-04-06
99
Participants Needed
1
Research Sites
917 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
CONDITIONS
Official Title
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age or older
- Ability to give informed consent
- Diagnosis of Stage I to III breast malignancy
You will not qualify if you...
- Unable to tolerate venipuncture
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States, 43210
Actively Recruiting
Research Team
O
Ohio State Comprehensive Cancer Center
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here